NVRO
NEVRO CORP.
NVRO
NVRO
Delisted
NVRO was delisted on the 2nd of April, 2025.
About: Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Employees: 1,099
Financial journalist opinion
Charts implemented using
Lightweight Charts™